Kringle Pharma (4884) · PolicyRestated
Policy of protecting manufacturing methods as undisclosed know-how
First written in FY2020. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Protecting and Strengthening Core Value through Intellectual Property ManagementA theme 42 companies write about · 0 as a headwind · 42 as a tailwind
15 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 42 companies compared. The sentences above are computed from all 42.Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「For both products, we have adopted a strategy of not filing patents for the manufacturing methods and not disclosing them as know-how.」
原薬・凍結乾燥製剤の製造方法を非公表ノウハウとして保護する方針を継続している。 - FY2020First statedAnnual report
「For both products, we have adopted a strategy of not filing patents for the manufacturing methods and not disclosing them as know-how.」
For API and lyophilized formulation manufacturing methods, the company has chosen to manage know-how through confidentiality agreements and other measures rather than patent filings.